Surgery Partners (SGRY) PT Raised to $55 at Stifel
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/20/2026
- US stock futures steady after tech slump; investors focus on Middle East tensions
- U.S. Treasury doubles buyback operation size for long-dated bonds
- Marvell shares jump after giving Google warrants amid custom chip deal
- U.S. debt tops $40 trillion
- Nvidia credit risk gauge hits new peak as SoftBank readies record bond issue
- Marvell issues Google warrant tied to custom chip deal
- FOMC minutes from July 28-29th meeting
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- US stock futures steady after tech slump; investors focus on Middle East tensions
- Marvell shares jump after giving Google warrants amid custom chip deal
Surgery Partners (SGRY) PT Raised to $55 at Cowen
March 1, 2022 7:23 AM ESTCowen analyst Gary Taylor raised the price target on Surgery Partners (NASDAQ: SGRY) to $55.00 (from $52.00) while maintaining a Market Perform rating.
The analyst commented, "Excluding CARES Provider Relief Funds, SGRY narrowly missed 4Q21 estimates despite the Omicron surge. 2022 EBITDA guidance was raised just... More
Surgery Partners (SGRY) PT Lowered to $65 at RBC Capital
March 1, 2022 6:17 AM ESTRBC Capital analyst Frank Morgan lowered the price target on Surgery Partners (NASDAQ: SGRY) to $65.00 (from $70.00) while maintaining a Outperform rating.... More
